Throughout a decade of working with 501(c)(3) non-profits, pre-seed to Series B startups, academia, investors, corporates, and agencies working with biotech and emerging technologies, I’ve just about seen it all.
I understand:
- the immovable realities of limited time, resources, and budgets. As they say in law, “You cannot draw blood from a stone”
- the extreme pressure that teams, and especially founders, are under
- as a former outsider myself, how difficult it can be to navigate the complex, and at times cringeworthy worlds of biotech and emerging technologies as a newcomer, to diligence confusing technologies promising the world – and to then venture further into uncharted waters as a champion for these novel and often unproven innovations as an investor, or within a corporate environment in an unrelated industry
- the unprecedented macro factors that all businesses today are currently faced with, which weren’t covered in past playbooks and add further risk and uncertainty to decision-making
- and how high the stakes are for all involved.
Because I’ve been there myself, on the ground and up against the same seemingly impossible odds.
Companies working with biology and other novel technologies face unique challenges that very few people on the planet have first-hand knowledge of.
I can share from lived experience what works, and what doesn’t – and help you achieve your goals, whether you’re a founder, functional lead, investor, or represent a company considering engaging with biotechnology, now or in the future.
My background and expertise enable me to consider many aspects of your business, technology, and objectives, which most agencies and practitioners lacking firsthand experience, care, and attention to detail miss.
I integrate seamlessly with technical, business development, sales, legal, and finance teams, and work closely with you and the appropriate leaders to achieve your desired results.
